Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisa rtan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure
Condition: Hypertension Interventions: Drug: Spironolactone; Drug: Indapamide Sponsor: Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 2, 2020 Category: Research Source Type: clinical trials
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
Conditions: Cognitive Decline; Intracerebral Hemorrhage; Dementia, Vascular; Cerebral Small Vessel Diseases; Hypertension; Stroke Hemorrhagic Interventions: Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg; Drug: Placebo oral capsule Sponsors: The George Institute; University of Sydney Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2018 Category: Research Source Type: clinical trials
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) MRI Sub-study
Conditions: Stroke; Cerebral Small Vessel Diseases; Intracerebral Hemorrhage; Vascular Dementia; Hypertension Interventions: Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg; Drug: Placebo oral capsule Sponsors: The George Institute; University of Sydney Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2018 Category: Research Source Type: clinical trials
